Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Research Briefing
  • Published:

Stem-cell-based functional genomics for the large-scale analysis of genetic variants

We functionally assessed clinically observed mutations of the BRCA2 gene and analysed structure–function relationships of variants of the gene by using high-throughput CRISPR-mediated mutagenesis and pooled screening in locally haploid human pluripotent stem cells and in fibroblasts differentiated from them.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Schematic representation of the use of loHAPs to annotate genetic variants.

References

  1. Lord, C. J. & Ashworth, A. PARP inhibitors: synthetic lethality in the clinic. Science 355, 1152–1158 (2017). A review article that presents the mechanism and clinical effectiveness of PARPi on cancers with defective DNA repair.

    Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

  2. Kass, E. M., Lim, P. X., Helgadottir, H. R., Moynahan, M. E. & Jasin, M. Robust homology-directed repair within mouse mammary tissue is not specifically affected by Brca2 mutation. Nat. Commun. 7, 13241 (2016). This paper reports tissue-specific reliance on homology-directed repair to fix DNA damage in murine tissue.

    Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

  3. Brnich, S. E. et al. Recommendations for application of the functional evidence PS3/BS3 criterion using the ACMG/AMP sequence variant interpretation framework. Genome Med. 12, 3 (2019). This paper outlines the recommendations of the American College of Medical Genetics and Genomics for how functional evidence should be evaluated in classifying variants in patients.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Rebbeck, T. R. et al. Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer. JAMA 313, 1347–1361 (2015). This paper reports mutation-specific cancer risks for carriers of BRCA1 and BRCA2 mutations.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Findlay, G. M. et al. Accurate classification of BRCA1 variants with saturation genome editing. Nature 562, 217–222 (2018). This paper reports the annotation of BRCA1 variants using saturation genome editing in HAP1 cells.

    Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This is a summary of: Li, H. et al. Functional annotation of variants of the BRCA2 gene via locally haploid human pluripotent stem cells. Nat. Biomed. Eng. https://doi.org/10.1038/s41551-023-01065-7 (2023).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Stem-cell-based functional genomics for the large-scale analysis of genetic variants. Nat. Biomed. Eng 8, 114–115 (2024). https://doi.org/10.1038/s41551-023-01066-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41551-023-01066-6

Search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer